APTEVO THERAPEUTICS INC (APVO) Stock Balance Sheet
USA - NASDAQ:APVO - US03835L5049 - Common Stock
1.71 USD
-0.05 (-2.84%)
1.71 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 8.10M | 1.18M | 3.73M | 1.07M | 3.84M | |||
| Cash Equivalents | 1.31M | 7.53M | 13.17M | 21.57M | 41.20M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | 0.00 | 2.50M | 3.66M | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.67M | 1.95M | 2.16M | 2.31M | 3.86M | |||
| Total Current Assets | 11.08M | 10.66M | 19.07M | 27.45M | 52.57M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.54M | 4.93M | 5.78M | 6.76M | 3.96M | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | 68.00K | |||
| Total Non-Current Assets | 4.54M | 4.93M | 5.78M | 6.76M | 4.03M | |||
| TOTAL ASSETS | 15.62M | 15.59M | 24.84M | 34.22M | 56.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 2.00M | 11.67M | |||
| Accrued Expenses | 1.84M | 2.66M | 2.80M | 2.50M | 3.10M | |||
| Accounts Payable | 2.90M | 3.05M | 3.98M | 3.50M | 3.46M | |||
| Other Current Liabilities | 148.00K | 498.00K | 442.00K | 702.00K | 16.53M | |||
| Total Current Liabilities | 4.89M | 6.21M | 7.22M | 8.71M | 34.76M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 1.46M | 3.71M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 4.21M | 4.63M | 5.40M | 6.08M | 16.92M | |||
| Total Non-Current Liabilities | 4.21M | 4.63M | 5.40M | 7.54M | 20.63M | |||
| TOTAL LIABILITIES | 9.10M | 10.84M | 12.62M | 16.24M | 55.38M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -260.19M | -247.58M | -223.45M | -206.04M | -214.06M | |||
| Additional Paid In Capital | 266.61M | 252.25M | 235.61M | 223.96M | 215.23M | |||
| Common Shares | 99.00K | 84.00K | 61.00K | 48.00K | 47.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Shares Outstanding | 3.22M | 2.00K | 600.00 | 200.00 | 100.00 | |||
| Tangible Book Value per Share | 2.02 | 2.41K | 27.65 | 122.27 | 10.96 | |||
| Total Shareholders' Equity | 6.52M | 4.75M | 12.22M | 17.97M | 1.22M | |||
| TOTAL LIABILITIES AND EQUITY | 15.62M | 15.59M | 24.84M | 34.22M | 56.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.08 | 3.05 | |||
| Current Ratio | 2.27 | 1.72 | 2.64 | 3.15 | 1.51 | |||
| Return On Assets (ROA) | -153.77% | -153.93% | -70.09% | 23.46% | -50.28% | |||
| Return On Equity (ROE) | -368.26% | -504.73% | -142.47% | 44.66% | -2340.21% | |||
All data in USD , ROIC based on taxRate of 0.21